Increase of hematopoietic responses by triple or single helical conformer of an antitumor (1→3)-β-D-Glucan preparation, sonifilan, in cyclophosphamide-induced leukopenic mice

Bioscience, Biotechnology and Biochemistry

Volumn 63, Issue 1, 1999, Pages 104-110

  Tsuzuki, Aiko ^a   Tateishi, Tomoko ^a   Ohno, Naohito ^a   Adachi, Yoshiyuki ^a   Yadomae, Toshiro ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Cyclophosphamide; Cytokine; Hematopoietic response; Transplantation; glucan

Indexed keywords

ANTINEOPLASTIC AGENT; BETA 1,3 GLUCAN; BETA GLUCAN; BETA-1,3-GLUCAN; COLONY STIMULATING FACTOR 1; CYCLOPHOSPHAMIDE; CYTOKINE; GLUCAN; INTERLEUKIN 6; MESSENGER RNA; PRIMER DNA; SCHIZOPHYLLAN; STEM CELL FACTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CLONOGENIC ASSAY; CONFORMATION; DRUG EFFECT; GENE EXPRESSION; GENETICS; HEMATOPOIESIS; INSTITUTE FOR CANCER RESEARCH MOUSE; LEUKOCYTE COUNT; LEUKOPENIA; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BETA-GLUCANS; CARBOHYDRATE CONFORMATION; COLONY-FORMING UNITS ASSAY; CYCLOPHOSPHAMIDE; CYTOKINES; DNA PRIMERS; GENE EXPRESSION; GLUCANS; HEMATOPOIESIS; INTERLEUKIN-6; LEUKOCYTE COUNT; LEUKOPENIA; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED ICR; RNA, MESSENGER; SIZOFIRAN; STEM CELL FACTOR;

EID: 0032615984     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.63.104     Document Type: Article

References (28)

1. Chauvergne, J., Chinet-Charrot, P., Stockle, E., Thomas, L., and Toulouse, C., Carboplatin and etoposide combination for the treatment of recurrent epithelial ovarian cancer. Bull. Cancer (Paris), 83, 315-323 (1996).
2. Pronk, L. C., Stoter, G., and Verweij, J., Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effects. Cancer Treat. Rev., 21, 463-478 (1995).
3. Cascinu, S., Management of diarrhea induced by tumors or cancer therapy. Curr. Opin. Oncol., 7, 325-329 (1995).
4. Höchster, H., Wasserheit, C., and Speyer, J., Cardiotoxicity and cardioprotection during chemotherapy. Curr. Opin. Oncol., 7, 304-309 (1995).
5. McDonald, S., Rubin, P., Phillips, T. L., and Marks, L. B., Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int. J. Radiat. Oncol. Biol. Phys., 31, 1187-1203 (1995).
6. van der Vijgh, W. J., and Peters, G. J., Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (Ethyol): preclinical aspects. Semin. Oncol., 21, 2-7 (1994).
7. Clark, S. C., and Kamen, R., The Human Hematopoietic Colony-Stimulating Factors. Science, 236, 1229-1237, (1987).
8. Bociek, R. G. and Armitage, J. O., Hematopoietic growth factors. CA Cancer J. Clin. 46, 165-184 (1996).
9. Riikonen, P., Recombinant human granulocyte-macrophage colony-stimulating factor in combination with antibiotics in the treatment of febrile neutropenia in children. Stem Cells (Dayt), 13, 201-205 (1995).
10. Bokemeyer, C., Kuczyk, M. A., Kohne, H., Einsele, H., Kynast, B., and Schmoll, H. J., Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy. Ann. Hematol., 72, 1-9 (1996).
11. Iida, S., Matsuoka, S., Kudo, C., Moriya, Y., Yoshida, T., and Saito, M., Combination chemo-immunotherapy of murine solid tumor with OK-432, G-CSF, IL-2, and chemotherapeutics. Int. J. Immunopharmacol. 17, 973-80 (1995).
12. Matuo, T., Asano, T., and Mitani, M., Augmentation of host cellular immunity by Schizophyllan (SPG), an antitumor polysaccharide. Yakuri to chiryou (in Japanese), 9, 1835-1843, (1981).
13. Shimizu, T., Nomoto, K., Yokokura, T., and Mutai, M., Role of colony-stimulating activity in antitumor activity of Lactobacillus casei in mice. J. Leuk. Biol., 42, 204-212 (1987).
14. Hoshino, T. and Uchida, A., OK-432, Recent investigations on its effective mechanisms and optimal therapeutic protocol. Biotherapy, 2, 486-495 (1988).
15. Hashimoto, K., Suzuki, I., Ohsawa, M., Oikawa, S., and Yadomae, T., Enhancement of hematopoietic response of mice by intraperitoneal administration of α /Tglucan, SSG, obtained from Sclerotinia sclerotiorum. J. Pharmacobio-dyn., 13, 512-517, (1990).
16. Ohno, N., Miura, N. N., Chiba, N., Adachi, Y., and Yadomae, T., Comparison of the immunopharmacological activities of triple and single-helical schizophyllan in mice. Biol. Pharm. Bull., 18, 1242-1247, (1995).
17. Yadomae, T. and Ohno, N., Structure-activity relationship of im-munomodulating endo-β-D-glucans. Recent Research Develop. Chem. & Pharm. Sciences, 1, 23-33, (1996).
18. Sakagami, Y., Mizoguchi, Y., Shin, T., Seki, S., Kobayashi, K., Morisawa, S., and Yamamoto, S., Effects of an anti-tumor polysaccharide, schizophyllan, on interferon-gamma and interleukin 2 production by peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun., 155, 650-5 (1988).
19. Itoh, T., Teramoto, A., Matsuo, T., and Suga, H., Ordered structure in aqueous polysaccharide. 5. Cooperative order-dis-order transition in aqueous schizophyllan. Macromolecules, 19, 1234-1240 (1986).
20. Norisuye, T., Yanaki, T., and Fujita, H., Triple helix of a Schizophyllum commune polysaccharide in aqueous solution. J. Polym. Sci. Polym. Phys. Edit., 18, 547-558 (1980).
21. Yanaki, T., Norisuye, T., and Fujita, H., Triple helix of Schizophyllum commune polysaccharide in dilute solution. 3. Hydrodynamic properties in water. Macromolecules, 13, 1462-1466 (1980).
22. Ohno, N., Egawa, Y., Hashimoto, T., Adachi, Y., and Yadomae, T., Effect of β-glucans on the nitric oxide synthesis by peritoneal macrophage in mice. Biol. Pharm. Bull., 19, 608-612, (1996).
23. Miura, N. N., Ohno, N., Adachi, Y., Aketagawa, J., Tamura, H., Tanaka, S., and Yadomae, T., Application of limulus test (G pathway) for the detection of different conformers of (1 → 3)-β-D-glucans. Biol. Pharm. Bull., 16, 822-828, (1993).
24. Ohno, N., Hashimoto, T., Adachi, Y., and Yadomae, T., Conformation dependency of nitric oxide synthesis of murine peritoneal macrophages by yS-glucans in vitro. Immunology letters, 52, 1-7, (1996).
25. Tritarellij E., Greco, G., Testa, U., Belaredelli, F., Peschle, C., and Proietti, E., Combined interleukin-1 beta/ interleukin-6 treatment in mice: synergistic myelostimulatory activity and my-elorestorative effect after cyclophosphamide-induced myelosup-pression. Cancer Res, 54, 6469-6476, (1994).
26. Bryniarski, K., Ptak, M., Ptak, W., The in vivo and in vitro effects of an alkylating agent, mechlorethamine on IL-6 production in mice and role of macrophages. Immunopharmacology, 34, 73-78, (1996).
27. Jacques Van Snick, Interleukin-6: an Overview. Annu. Rev. Immunol., 8, 253-278, (1990).
28. Williams, NS., Moore, TA., Schatzle, JD., Puzanov, IJ., Sivakumar, PV., Zlotnik, A., Bennett, M., and Kumar, V., Generation of lytic killer 1.1 +, Ly-49- cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J. Exp. Med., 186, 1609-1614, (1997).